Skip to content

GCF Levels of IL-1β and IL-6 in Gingivitis and Stage III-Grade C Periodontitis

Usak University Faculty of Dentistry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04689438
Enrollment
64
Registered
2020-12-30
Start date
2020-10-08
Completion date
2020-12-28
Last updated
2022-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Keywords

periodontal disease, periodontitis, gingivitis, cytokines

Brief summary

Periodontal diseases are chronic diseases that occur as a result of a violation of the balance between microbial dental plaque and the host response. Gingivitis is a disease characterized by inflammation of the gingiva that occurs in one or more areas without loss of attachments.1 in periodontitis, an inflammatory event that begins in the gingiva along with gingivitis spreads to the periodontal ligament, alveolar bone and soft tissues that support the tooth, causing the destruction of these structures.2 Cytokines are low molecular weight proteins that participate in the initial and active stages of inflammation and immunity. In periodontal disease pathogenesis, cytokine response has been reported to play a very critical role in determining disease progression.3 IL-1beta and IL-6 are key cytokines in chronic inflammatory diseases and have the potential to initiate bone loss and tissue destruction seen in periodontal disease.4the purpose of this study; it is to determine the degree of inflammation and periodontal destruction by determining the levels of IL-1beta and IL-6 cytokines in the gingival crevicular fluid of periodontal healthy and diseased individuals.

Detailed description

Periodontal measurement were done at 6 sites per tooth After clinical evaluation, individuals were divided into 3 groups 1. Healthy control groups: clinically healthy gingiva 2. Gingivitis groups: BOP score of 10% or greater and PD≤3mm 3. Periodontitis groups: AL ≥5 mm, PD≥6 mm and tooth loss due to periodontitis of ≤4. GCF samples were collected using strips.

Interventions

GCF samples were collected in the morning hours 24-48 hours after clinical periodontal measurement.

Sponsors

Uşak University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* have periodontitis * have 16 permanent teeth

Exclusion criteria

* Systemic disease * using drugs

Design outcomes

Primary

MeasureTime frameDescription
Measurement of IL-1Beta levelGCF was taken within 1 week after clinical examinationGCF was taken interproximal region.
Measurement of IL-6 level in GCFGCF was taken within 1 week after clinical examinationGCF was taken interproximal region.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026